Johnson & Johnson – Page 2

FDA Issues Alert on Heart Pump Linked to Deaths

The agency faulted the device maker for delayed notice of mounting complications, citing increasing reports of how use of the device perforated the walls of the heart.

By Christina Jewett

Bristol Myers Squibb Company Drugs (Pharmaceuticals) Johnson & Johnson Merck & Company Inc Prices (Fares, Fees and Rates) Sanders, Bernard Senate Senate Committee on Health, Education, Labor and Pensions United States Politics and Government

J&J, Merck and Bristol Myers Squibb CEOs Will Testify at Senate Hearing on Drug Prices

The top executives of three major companies are set to appear on Thursday before a Senate panel led by Mr. Sanders, who has made lowering drug costs a signature issue.

By Noah Weiland and Rebecca Robbins

Bankruptcies Cancer Decisions and Verdicts Hazardous and Toxic Substances Johnson & Johnson Suits and Litigation (Civil)

Judge Rejects Johnson & Johnson’s Effort to Limit Talc-Related Liabilities

A bankruptcy court’s ruling was the second time the company was rebuffed in its attempt to settle thousands of lawsuits that claim its products caused cancer.

By Nicole Sperling

Biden, Joseph R Jr Bristol Myers Squibb Company Centers for Medicare and Medicaid Services Drugs (Pharmaceuticals) Health and Human Services Department Health Insurance and Managed Care Inflation Reduction Act of 2022 Johnson & Johnson Law and Legislation Medicare Merck & Company Inc Pharmaceutical Research and Manufacturers of America Prices (Fares, Fees and Rates) Suits and Litigation (Civil) United States Chamber of Commerce United States Politics and Government

Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations

The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.

By Sheryl Gay Stolberg and Rebecca Robbins